Beth Blumhoefer, Director of Tax at Pacira Pharmaceuticals will be speaking at the Tax Officers this November!
Contributed by marcus evans
25 September, 2018
Marcus Evans is very proud to announce Beth Blumhoefer, Director of Tax at Pacira Pharmaceuticals, Inc. as a speaker at the Tax Officers Summit which will be taking place at The Langham Huntington, Pasadena in Los Angeles, California from the 8th - 10th of November, 2018.
Beth Blumhoefer has been the Tax Director at Pacira Pharmaceuticals (a US company with operations in both the US and UK) since 2016. In her current role, Beth is responsible for compliance and accounting for income taxes, sales and use taxes, and property taxes, as well as international tax matters including transfer pricing and VAT.
Prior to joining Pacira, Beth spent 10 years at Novartis as part of their US tax department, building and managing sub-teams of various sizes.
Beth has extensive experience with hiring, talent evaluation and management, and strategic workload allocation. She believes that an empowered, engaged, and happy team is critically important to productivity in the long term.
At the Tax Officers Summit, Beth will be speaking about 'Talent and Retention Strategies: Feeding the Desire of New Millennials'. Retaining a talented workforce is intrinsically connected to the success of a business and an important goal for a tax officer to achieve. Engaging and motivating millennials contributes to their level of interest and desired commitment to the business. As a tax executive, it is good practice to take a strong interest in the development of the team since finding replacements is costly and time consuming. The aim of the presentation is to discover and explore:
- Techniques to analyze talent within the workforce
- Ways to compliment employee retention strategies to help keep top talent and maintain productivity
- Effective employee retention programs and measure the success
For more information on the Tax Officers Summit
Or contact: Mina Chrysanthou
Digital Media & PR Executive
+ 357 22 849 336
« Go Back to Press Releases